ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Eight Practicing Physicians On Board are Enough, Need Some Scientists Now, DeVita Says

December 9, 1983

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

NCI Contracts: Advisors OK Renewal Of chemoprevention Contracts By DCPC

September 6, 1996

Cancer Control Budget Still $4 Million Short

January 28, 1977

Adjuvant Radiation Treatment Shows Improved Survival In Elderly, Early-Stage Patients

November 30, 2012